For how we live.
An analysis of 15 years of case data from Altamira, in the Xingu Basin, finds forest edge and local population size — not climate — explained where transmission returned.
A Lancet evaluation of the RTS,S introduction in Ghana, Kenya and Malawi reports a 13% drop in mortality among vaccine-eligible children — achieved with third-dose coverage of 71% and fourth-dose uptake under 40%.
The estimate covers 2000 to 2023 and 108 countries. It is a counterfactual model, not a measured saving, and it lands as the US and other donors debate cutting the disease-specific funding it credits.
Fourteen months after an undiagnosed febrile outbreak alarmed the world, sequencing and PCR on 108 patients found no novel pathogen — half had falciparum malaria and many had a respiratory co-infection.
The Lancet Global Health paper that produced this month's headline number also produced a larger one: 22.6 million additional deaths by 2030 if defunding deepens. The distinction matters more than the figure.
Washington intends to provide up to $792 million over five years. Malawi commits the rest — and the money is meant to flow through the government rather than NGOs.
The year-end immunization summary reports 88% fewer measles deaths since 2000, malaria vaccine in 24 African countries, and 25 years without wild polio in the Western Pacific.
In a 400-pair trial in Uganda where every family already had a bed net, insecticide-treated wraps reduced clinical malaria in infants from 2.14 to 0.73 cases per 100 person-weeks.
IHME's annual accounting puts development assistance for health at less than half its 2021 peak, with no recovery forecast to 2030. A companion model estimates what that means for tuberculosis.